Medigen Vaccine Biologics Statistics
Total Valuation
TPEX:6547 has a market cap or net worth of TWD 15.89 billion. The enterprise value is 14.32 billion.
Market Cap | 15.89B |
Enterprise Value | 14.32B |
Important Dates
The last earnings date was Tuesday, March 18, 2025.
Earnings Date | Mar 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6547 has 328.73 million shares outstanding. The number of shares has increased by 0.11% in one year.
Current Share Class | n/a |
Shares Outstanding | 328.73M |
Shares Change (YoY) | +0.11% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 0.29% |
Owned by Institutions (%) | 3.23% |
Float | 251.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 37.48 |
PS Ratio | 26.24 |
PB Ratio | 4.13 |
P/TBV Ratio | 4.16 |
P/FCF Ratio | 2,461.94 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -177.94 |
EV / Sales | 23.64 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 2,217.73 |
Financial Position
The company has a current ratio of 11.94, with a Debt / Equity ratio of 0.09.
Current Ratio | 11.94 |
Quick Ratio | 9.54 |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | 52.50 |
Interest Coverage | -7.71 |
Financial Efficiency
Return on equity (ROE) is -2.09% and return on invested capital (ROIC) is -1.82%.
Return on Equity (ROE) | -2.09% |
Return on Assets (ROA) | -1.74% |
Return on Invested Capital (ROIC) | -1.82% |
Return on Capital Employed (ROCE) | -3.51% |
Revenue Per Employee | 5.88M |
Profits Per Employee | -781,214 |
Employee Count | 103 |
Asset Turnover | 0.12 |
Inventory Turnover | 0.50 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.60% in the last 52 weeks. The beta is 1.09, so TPEX:6547's price volatility has been similar to the market average.
Beta (5Y) | 1.09 |
52-Week Price Change | -8.60% |
50-Day Moving Average | 50.13 |
200-Day Moving Average | 45.85 |
Relative Strength Index (RSI) | 41.63 |
Average Volume (20 Days) | 2,550,616 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6547 had revenue of TWD 605.64 million and -80.47 million in losses. Loss per share was -0.24.
Revenue | 605.64M |
Gross Profit | 396.42M |
Operating Income | -145.67M |
Pretax Income | -80.47M |
Net Income | -80.47M |
EBITDA | -26.16M |
EBIT | -145.67M |
Loss Per Share | -0.24 |
Balance Sheet
The company has 1.92 billion in cash and 338.96 million in debt, giving a net cash position of 1.58 billion or 4.80 per share.
Cash & Cash Equivalents | 1.92B |
Total Debt | 338.96M |
Net Cash | 1.58B |
Net Cash Per Share | 4.80 |
Equity (Book Value) | 3.85B |
Book Value Per Share | 11.71 |
Working Capital | 2.34B |
Cash Flow
In the last 12 months, operating cash flow was 40.75 million and capital expenditures -34.30 million, giving a free cash flow of 6.46 million.
Operating Cash Flow | 40.75M |
Capital Expenditures | -34.30M |
Free Cash Flow | 6.46M |
FCF Per Share | 0.02 |
Margins
Gross margin is 65.46%, with operating and profit margins of -24.05% and -13.29%.
Gross Margin | 65.46% |
Operating Margin | -24.05% |
Pretax Margin | -13.29% |
Profit Margin | -13.29% |
EBITDA Margin | -4.32% |
EBIT Margin | -24.05% |
FCF Margin | 1.07% |
Dividends & Yields
TPEX:6547 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.11% |
Shareholder Yield | -0.11% |
Earnings Yield | -0.51% |
FCF Yield | 0.04% |
Stock Splits
The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.
Last Split Date | Aug 3, 2022 |
Split Type | Forward |
Split Ratio | 1.48280574 |
Scores
TPEX:6547 has an Altman Z-Score of 19.79.
Altman Z-Score | 19.79 |
Piotroski F-Score | n/a |